Medicine
fromwww.scientificamerican.com
9 hours agoDrugs like Ozempic are improving kidney treatment and changing lives
GLP-1 receptor agonists, finerenone, and SGLT2 inhibitors represent breakthrough treatments for chronic kidney disease, with combined therapy potentially adding decades to patients' lives.